Functional activation of β-adrenergic receptors by thiols in the presence or absence of agonists

S. E. Pedersen, E. M. Ross

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Treatment of β-adrenergic receptor with dithiothreitol (DTT) or other thiol compounds caused its functional activation in the presence or absence of agonist ligands. Such activation was observed in reconstituted unilamellar phospholipid vesicles that contained β-adrenergic receptors, purified to ≥ 95% homogeneity from turkey erythrocyte plasma membranes, and the stimulatory GTP-binding protein of the adenylate cyclase system (G(s)) purified from rabbit liver. Incubation of the vesicles with 2-10 mM DTT at 0° C for 1 h increased the rate (4-5-fold) and the extent (3-4-fold) of activation of G(s) by guanosine 5'-O-(3-thiotriphosphate) (GTPγS) binding, an effect about equivalent to the addition of β-adrenergic agonists. Treatment with DTT also markedly potentiated the ability of agonists to stimulate GTPγS binding, increasing the initial rate about 10-fold. DTT treatment was as effective as agonist in stimulating GTPase activity and maximal stimulation was obtained when DTT-treated vesicles were assayed in the presence of agonist. Other thiol compounds produced effects similar to those of DTT but were at least 10-fold less potent. Stimulation of GTPγS binding or GTPase activity required active receptor, and treatment of the receptor with DTT prior to reconstitution also increased its efficacy. There was no effect of DTT on G(s) alone. Thus, the site of action of DTT appears to be on the β-adrenergic receptor itself, and the reduction of disulfides and the binding of agonist act synergistically to activate the receptor. DTT treatment made the receptor more labile to thermal denaturation. Inclusion of cholesterol or cholesteryl-hemisuccinate (5-25%) in the vesicles protected the reduced receptor against such denaturation and enhanced its recovery during reconstitution. No effect of cholesterol or cholesteryl-hemisuccinate was observed on the stability of the nonreduced receptor, which was comparable to that observed in native membranes.

Original languageEnglish (US)
Pages (from-to)14150-14157
Number of pages8
JournalJournal of Biological Chemistry
Volume260
Issue number26
StatePublished - 1985

Fingerprint

Dithiothreitol
Sulfhydryl Compounds
Adrenergic Receptors
Chemical activation
Guanosine 5'-O-(3-Thiotriphosphate)
Denaturation
GTP Phosphohydrolases
Cholesterol
Enhanced recovery
Therapeutics
Unilamellar Liposomes
Adrenergic Agonists
Erythrocyte Membrane
Cell membranes
GTP-Binding Proteins
Adenylyl Cyclases
Disulfides
Liver
Phospholipids
Hot Temperature

ASJC Scopus subject areas

  • Biochemistry

Cite this

Functional activation of β-adrenergic receptors by thiols in the presence or absence of agonists. / Pedersen, S. E.; Ross, E. M.

In: Journal of Biological Chemistry, Vol. 260, No. 26, 1985, p. 14150-14157.

Research output: Contribution to journalArticle

@article{1ed5a5a37c304e349e1a2ebed057d4b1,
title = "Functional activation of β-adrenergic receptors by thiols in the presence or absence of agonists",
abstract = "Treatment of β-adrenergic receptor with dithiothreitol (DTT) or other thiol compounds caused its functional activation in the presence or absence of agonist ligands. Such activation was observed in reconstituted unilamellar phospholipid vesicles that contained β-adrenergic receptors, purified to ≥ 95{\%} homogeneity from turkey erythrocyte plasma membranes, and the stimulatory GTP-binding protein of the adenylate cyclase system (G(s)) purified from rabbit liver. Incubation of the vesicles with 2-10 mM DTT at 0° C for 1 h increased the rate (4-5-fold) and the extent (3-4-fold) of activation of G(s) by guanosine 5'-O-(3-thiotriphosphate) (GTPγS) binding, an effect about equivalent to the addition of β-adrenergic agonists. Treatment with DTT also markedly potentiated the ability of agonists to stimulate GTPγS binding, increasing the initial rate about 10-fold. DTT treatment was as effective as agonist in stimulating GTPase activity and maximal stimulation was obtained when DTT-treated vesicles were assayed in the presence of agonist. Other thiol compounds produced effects similar to those of DTT but were at least 10-fold less potent. Stimulation of GTPγS binding or GTPase activity required active receptor, and treatment of the receptor with DTT prior to reconstitution also increased its efficacy. There was no effect of DTT on G(s) alone. Thus, the site of action of DTT appears to be on the β-adrenergic receptor itself, and the reduction of disulfides and the binding of agonist act synergistically to activate the receptor. DTT treatment made the receptor more labile to thermal denaturation. Inclusion of cholesterol or cholesteryl-hemisuccinate (5-25{\%}) in the vesicles protected the reduced receptor against such denaturation and enhanced its recovery during reconstitution. No effect of cholesterol or cholesteryl-hemisuccinate was observed on the stability of the nonreduced receptor, which was comparable to that observed in native membranes.",
author = "Pedersen, {S. E.} and Ross, {E. M.}",
year = "1985",
language = "English (US)",
volume = "260",
pages = "14150--14157",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "26",

}

TY - JOUR

T1 - Functional activation of β-adrenergic receptors by thiols in the presence or absence of agonists

AU - Pedersen, S. E.

AU - Ross, E. M.

PY - 1985

Y1 - 1985

N2 - Treatment of β-adrenergic receptor with dithiothreitol (DTT) or other thiol compounds caused its functional activation in the presence or absence of agonist ligands. Such activation was observed in reconstituted unilamellar phospholipid vesicles that contained β-adrenergic receptors, purified to ≥ 95% homogeneity from turkey erythrocyte plasma membranes, and the stimulatory GTP-binding protein of the adenylate cyclase system (G(s)) purified from rabbit liver. Incubation of the vesicles with 2-10 mM DTT at 0° C for 1 h increased the rate (4-5-fold) and the extent (3-4-fold) of activation of G(s) by guanosine 5'-O-(3-thiotriphosphate) (GTPγS) binding, an effect about equivalent to the addition of β-adrenergic agonists. Treatment with DTT also markedly potentiated the ability of agonists to stimulate GTPγS binding, increasing the initial rate about 10-fold. DTT treatment was as effective as agonist in stimulating GTPase activity and maximal stimulation was obtained when DTT-treated vesicles were assayed in the presence of agonist. Other thiol compounds produced effects similar to those of DTT but were at least 10-fold less potent. Stimulation of GTPγS binding or GTPase activity required active receptor, and treatment of the receptor with DTT prior to reconstitution also increased its efficacy. There was no effect of DTT on G(s) alone. Thus, the site of action of DTT appears to be on the β-adrenergic receptor itself, and the reduction of disulfides and the binding of agonist act synergistically to activate the receptor. DTT treatment made the receptor more labile to thermal denaturation. Inclusion of cholesterol or cholesteryl-hemisuccinate (5-25%) in the vesicles protected the reduced receptor against such denaturation and enhanced its recovery during reconstitution. No effect of cholesterol or cholesteryl-hemisuccinate was observed on the stability of the nonreduced receptor, which was comparable to that observed in native membranes.

AB - Treatment of β-adrenergic receptor with dithiothreitol (DTT) or other thiol compounds caused its functional activation in the presence or absence of agonist ligands. Such activation was observed in reconstituted unilamellar phospholipid vesicles that contained β-adrenergic receptors, purified to ≥ 95% homogeneity from turkey erythrocyte plasma membranes, and the stimulatory GTP-binding protein of the adenylate cyclase system (G(s)) purified from rabbit liver. Incubation of the vesicles with 2-10 mM DTT at 0° C for 1 h increased the rate (4-5-fold) and the extent (3-4-fold) of activation of G(s) by guanosine 5'-O-(3-thiotriphosphate) (GTPγS) binding, an effect about equivalent to the addition of β-adrenergic agonists. Treatment with DTT also markedly potentiated the ability of agonists to stimulate GTPγS binding, increasing the initial rate about 10-fold. DTT treatment was as effective as agonist in stimulating GTPase activity and maximal stimulation was obtained when DTT-treated vesicles were assayed in the presence of agonist. Other thiol compounds produced effects similar to those of DTT but were at least 10-fold less potent. Stimulation of GTPγS binding or GTPase activity required active receptor, and treatment of the receptor with DTT prior to reconstitution also increased its efficacy. There was no effect of DTT on G(s) alone. Thus, the site of action of DTT appears to be on the β-adrenergic receptor itself, and the reduction of disulfides and the binding of agonist act synergistically to activate the receptor. DTT treatment made the receptor more labile to thermal denaturation. Inclusion of cholesterol or cholesteryl-hemisuccinate (5-25%) in the vesicles protected the reduced receptor against such denaturation and enhanced its recovery during reconstitution. No effect of cholesterol or cholesteryl-hemisuccinate was observed on the stability of the nonreduced receptor, which was comparable to that observed in native membranes.

UR - http://www.scopus.com/inward/record.url?scp=0022356539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022356539&partnerID=8YFLogxK

M3 - Article

C2 - 2997196

AN - SCOPUS:0022356539

VL - 260

SP - 14150

EP - 14157

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 26

ER -